Sage Therapeutic Com (SAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 2,864 | 1,739 | 1,501 | 1,582 | 1,642 |
| Cost of Goods | 143 | 184 | 200 | 286 | 87 |
| Gross Profit | 2,721 | 1,555 | 1,301 | 1,296 | 1,555 |
| Operating Expenses | 156,767 | 143,219 | 129,908 | 124,781 | 127,129 |
| Operating Income | -153,903 | -141,480 | -128,407 | -123,199 | -125,487 |
| Other Income | 6,757 | 4,157 | 2,147 | 1,144 | 775 |
| Pre-tax Income | -147,146 | -137,323 | -126,260 | -122,055 | -124,712 |
| Net Income Continuous | -147,146 | -137,323 | -126,260 | -122,055 | -124,712 |
| Net Income | $-147,146 | $-137,323 | $-126,260 | $-122,055 | $-124,712 |
| EPS Basic Total Ops | -2.47 | -2.31 | -2.13 | -2.07 | -2.12 |
| EPS Basic Continuous Ops | -2.47 | -2.31 | -2.13 | -2.07 | -2.12 |
| EPS Diluted Total Ops | -2.47 | -2.31 | -2.13 | -2.07 | -2.12 |
| EPS Diluted Continuous Ops | -2.47 | -2.31 | -2.13 | -2.07 | -2.12 |
| EBITDA(a) | $-154,942 | $-140,134 | $-125,547 | $-119,391 | $-120,830 |